Does de-escalation of antibiotic therapy for ventilator- associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically III surgical patients?

Journal of Trauma - Injury, Infection and Critical Care

Volumn 66, Issue 5, 2009, Pages 1343-1348

  Eachempati, Soumitra R ^a,b   Hydo, Lynn J ^a   Shou, Jian ^a   Barie, Philip S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE   (United States)

Author keywords

Antibiotic; Cycling, critically; De escalation; Pneumonia; Postoperative; Sepsis; Surgical; Trauma; VAP; Ventilator; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CILASTATIN PLUS IMIPENEM; DROTRECOGIN; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; ESCHERICHIA COLI; HEALTH CARE COST; HUMAN; INTENSIVE CARE UNIT; LUNG LAVAGE; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RECURRENT INFECTION; SCORING SYSTEM; SEPTIC SHOCK; SEX RATIO; SURGICAL PATIENT; VENTILATOR ASSOCIATED PNEUMONIA; ANALYSIS OF VARIANCE; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CRITICAL ILLNESS; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; FEMALE; FOLLOW UP; MALE; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MULTICENTER STUDY; PREDICTION AND FORECASTING; PROBABILITY; RECURRENT DISEASE; RISK; SURGERY; SURVIVAL; TREATMENT OUTCOME;

AGED; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; COHORT STUDIES; CONFIDENCE INTERVALS; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; ODDS RATIO; PNEUMONIA, VENTILATOR-ASSOCIATED; PREDICTIVE VALUE OF TESTS; PROBABILITY; RECURRENCE; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 67649639469     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31819dca4e     Document Type: Article

References (35)

1. Pieracci FM, Bane PS. Strategies in the prevention and management of ventilator-associated pneumonia. Am Surg. 2007;73:419-432.
2. Mayhall CG. Ventilator-associated pneumonia or not? Contemporary diagnosis. Emerg Infect Dis. 2001;7:200-204.
3. Rello J, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator- associated pneumonia. Chest. 1993;104:1230-1235.
4. Koontz CS, Chang MC, Meredith JW. Effects of empiric antibiotic administration for suspected pneumonia on subsequent opportunistic pulmonary infections. Am Surg. 2000;66:1110-1114.
5. Micek S, Heuring TJ, Hollands JM, Shah RA, Kollef MH. Optimizing antibiotic treatment for ventilator-associated pneumonia. Pharmacotherapy. 2006;26:204-213.
6. Niederman MS. The importance of de-escalating antimicrobial therapy in patients with ventilator-associated pneumonia. Sem Respir Crit Care Med. 2006;27:45-50.
7. Niederman MS. De-escalation therapy in ventilator-associated pneumonia. Curr Opin Crit Care. 2006;12:452-457.
8. Lisboa T, Rello J. De-escalation in lower respiratory tract infections. Curr Opin Pul Med. 2006;12:364-368.
9. Antonelli M, Mercurio G, Di Nunno S, Recchioni G, Deangelis G. De-escalation antimicrobial chemotherapy in critically III patients: pros and cons. J Chemother. 2001;13:218-223.
10. Davis KA. Ventilator-associated pneumonia: a review. J Intensive Care Med. 2006;21:211-226.
11. Barie PS, Hydo LJ, Eachempati SR. Causes and consequences of fever complicating critical surgical illness. Surg Infect. 2004;5:145-159.
12. O'Grady NP, Barie PS, Bartlett JG, et al. Practice guidelines for evaluating new fever in critically ill adult patients. Task Force of the Society of Critical Care Medicine and the Infectious Diseases Society of America. Clin Infect Dis. 1998;26:1042-1059,
13. Barie PS, Hydo LJ, Shou J, Larone DH, Eachempati SR. Influence of antibiotic therapy on mortality of critical surgical illness caused or, complicated by infection. Surg Infect. 2005;6:41-54.
14. Chastre J, Fagon JY, Soler P, et al. Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: " comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush. Am J Med. 1988;85:499-506.
15. Miller PR, Meredith JW, Chang MC. Optimal threshold for diagnosis of ventilator-associated pneumonia using bronchoalveolar lavage. J Trauma. 2003;55:263-267. ;
16. Croce MA, Fabian TC, Mueller EW, et al. The appropriate diagnostic threshold for ventilator-associated pneumonia using quantitative cultures. J Trauma. 2004;56:931-934.
17. Fujitani S, Yu VL. Diagnosis of ventilator-associated pneumonia: focus on nonbronchoscopic techniques (nonbronchoscopic bronchoalveolar lavage, including mini-BAL, blinded protected specimen brush, and blinded bronchial sampling) and endotracheal aspirates. J Intensive Care Med. 2006;21:17-21.
18. ' Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med. 2000;132:621-630.
19. Shorr AF, Sherner JH, Jackson WL, Kollef MH. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit Care Med. 2005;33:46-53.
20. Gross PA. Epidemiology of hospital acquired pneumonia. Semin Respir Infect. 1987;2:2-7.
21. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence on Infection in Intensive Care (EPIC) study. JAMA. 1995;274:639- 644.
22. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993; 94:281-288.
23. Crain CP, Connelly S. Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. Am J Infect Control. 1984;12:233-238.
24. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic : review. Crit Care Med. 2005;33:2184-2193.
25. American Thoracic Society Documents. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and heathcare-' associated pneumonia. Am J Resp Crit Care. 2005;171:3.88-416. '.
26. Kollef JM, Vlasnik J, Sharpless L, Pasque C, Murphy D, Fraser V. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997;156:1040-1048.
27. Warren DK, Hill HA, Merz LR, et al. Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram negative bacteria among intensive care unit patients. Crit Care Med. 2004; 32:2450-2456.
28. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 1997;111:676-685.
29. Leone M, Bourgoin A, Cambon S, Dubuc M, Albanese J, Martin C. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med. 2003;31:462-467.
30. Cadena J, Taboada CA, Burgess DS, et al. Antibiotic cycling to decrease bacterial antibiotic resistance: a 5-year experience on a bone marrow transplant unit. Bone Marrow Transplant. 2007;40:151-155.
31. Kollef MH. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit? Clin Infect Dis. 2006;43(Suppl 2):S82-S88.
32. Kollef M. Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time. Drugs. 2003;63:2157-2168.
33. Leone M, Garcin F, Bouvenot J, et al. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic abuse. Crit Care Med. 2007;35:379-385.
34. Rello J, Vidaur L, Sandiumenge A, et al. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med. 2004;32: 2183-2190.
35. Giantsou E, Liratzopoulos N, Efraimidou E, et al. De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate. Intensive Care Med. 2007;33:1533-1540.